Inkspace Imaging
Private Company
Total funding raised: $2.5M
Overview
InkSpace Imaging is a private, commercial-stage medical device company founded in 2017 and based in San Francisco. It has developed and commercialized a portfolio of ultra-lightweight, flexible MRI coils that are FDA-cleared and designed to address key pain points in radiology departments: patient discomfort, lengthy setup times, and workflow inefficiencies. By offering body-conforming coils compatible with all major scanner brands, the company targets improved image quality, faster throughput, and better patient experiences across diverse clinical and veterinary settings. Its products are already in use at hospitals and imaging centers, positioning it as a revenue-generating innovator in the diagnostic imaging hardware space.
Technology Platform
Design and manufacture of ultra-lightweight, flexible, body-conforming MRI receive coil arrays compatible with major 1.5T/3.0T scanners. Platform focuses on ergonomics, high channel count (12-48 channels) for accelerated imaging, and workflow efficiency.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competes directly with the in-house coil divisions of Siemens Healthineers, GE Healthcare, and Philips, which have deep customer relationships. Also competes with other specialized MRI coil manufacturers (e.g., NORAS, RAPID Biomedical) and generic coil providers. InkSpace's key differentiator is its focused combination of flexibility, lightweight design, and multi-vendor compatibility aimed at workflow improvement.